Centessa Pharmaceuticals News and Activities

Centessa Pharmaceuticals is owned by Eli Lilly.

Eli Lilly is one of the...

• Forbes Global 2000 (#71);
• Fortune 500 (#67);
• Global Fortune 500 (#336);
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

Eli Lilly is a company listed under the stock ticker LLY (US).

Eli Lilly has a direct presence in 18 countries.

Eli Lilly has 28 subsidiaries including 4E Therapeutics, Adverum Biotechnologies and Akouos.

They are in:

• Pharmaceuticals69%
• Biotechnology21%
• Other10%

Acquisition, funding and merger involving Eli Lilly.

• Eli Lilly has acquired Centessa Pharmaceuticals (posted on June 24 2026).
• Eli Lilly has announced the acquisition of Centessa Pharmaceuticals  (posted on March 31 2026).

View the org chart displaying its 31 main executives

Most searched biographies at Centessa Pharmaceuticals

• Christopher Stokes, Director
• Kristina Wright, Director
• Iqbal Hussain, Chief Legal Officer, Chief Compliance Officer and C...

Popular executive movements at Centessa Pharmaceuticals

• Kristina Wright has joined the company as Director  (posted on June 25 2026).
• Christopher Stokes has joined the company as Director  (posted on June 25 2026).
• Stephen Kanes, Chief Medical Officer and Head of Research and Development, has left the company  (posted on June 25 2026).

Click here to view some more movements at Centessa Pharmaceuticals

Popular executive movements at Eli Lilly

• Pranav Shroff, Director of Marketing, has left the company  (posted on July 1 2026).
• Jean Santana, who was Senior Director, Human Resources Business Partner, Manufacturing and Quality, is promoted to Senior Director, Global People Strategy, Manufacturing and Quality  (posted on May 13 2026).
• Jasmine Leong, who was Senior Director of International Market Alzheimer's Diagnostics, is promoted to Executive Director, International Brand, Alzheimer  (posted on May 4 2026).

Click here to view some more movements at Eli Lilly

Create your alert
to follow the executive moves at Centessa Pharmaceuticals.

Eli Lilly has 1,918 competitors including Sanofi (France), Moderna (United States (USA)) and Novartis (Switzerland).

Popular M&A news in Pharmaceuticals

• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).
• Ipsen has announced the acquisition of Memo Therapeutics  (posted on July 1 2026).
• Hanmi has acquired Aptose Biosciences (posted on July 1 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Tracey Franklin - Chief People and Digital Technology Officer at Moderna

Learn more about the Pharmaceuticals industry

Press releases by Centessa Pharmaceuticals

• Centessa Pharmaceuticals Announces Addition of Harris L. Rotman, PhD, as Senior Vice President of Regulatory Affairs | Centessa Pharmaceuticals
• Centessa Pharmaceuticals Announces Appointment of Dr. Mathias Hukkelhoven to its Board of Directors | Centessa Pharmaceuticals
• Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences | Centessa Pharmaceuticals
• Centessa Pharmaceuticals Announces Poster Presentation of First Preclinical Data for LockBody® Program at 2022 ASCO Annual Meeting | Centessa Pharmaceuticals
• Centessa Pharmaceuticals Makes Strategic Decision to Discontinue Clinical Development of Lixivaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Centessa Pharmaceuticals
• Centessa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Updates | Centessa Pharmaceuticals
• Centessa Pharmaceuticals Doses First Subject in Global Phase 3 ACTION Study of Lixivaptan in Autosomal Dominant Polycystic Kidney Disease | Centessa Pharmaceuticals
• Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update | Centessa Pharmaceuticals
• Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise | Centessa Pharmaceuticals
• Centessa Pharmaceuticals to Present at the Guggenheim Genomic Medicines & Rare Disease Day | Centessa Pharmaceuticals
• View more press releases Close

Social media about Centessa Pharmaceuticals

• Centessa Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Centessa Pharmaceuticals on LinkedIn, X (Twitter) & YouTube